April 14, 2021
Johnson and Johnson suspends EU rollout of coronavirus vaccine
Johnson & Johnson delayed the rollout of its coronavirus vaccine in Europe and South Africa temporarily paused administration of the vaccine. The decisions came after US health officials recommended pausing use of the vaccine due to six reported cases of blood clotting (out of 6.8M doses administered). A CDC advisory panel will review the cases today.